Page last updated: 2024-09-02

ecteinascidin 743 and indole-3-carbinol

ecteinascidin 743 has been researched along with indole-3-carbinol in 1 studies

Compound Research Comparison

Studies
(ecteinascidin 743)
Trials
(ecteinascidin 743)
Recent Studies (post-2010)
(ecteinascidin 743)
Studies
(indole-3-carbinol)
Trials
(indole-3-carbinol)
Recent Studies (post-2010) (indole-3-carbinol)
66010240465716250

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Colombo, T; D'Incalci, M; Donald, S; Falcioni, C; Gescher, AJ; Greaves, P; Jimeno, J; Manson, MM; Steward, WP; Verschoyle, RD; Zaffaroni, M; Zucchetti, M1

Other Studies

1 other study(ies) available for ecteinascidin 743 and indole-3-carbinol

ArticleYear
Dietary agent indole-3-carbinol protects female rats against the hepatotoxicity of the antitumor drug ET-743 (trabectidin) without compromising efficacy in a rat mammary carcinoma.
    International journal of cancer, 2004, Oct-10, Volume: 111, Issue:6

    Topics: Administration, Oral; Animals; Antineoplastic Agents, Alkylating; Antioxidants; Chemoprevention; Diet; Dioxoles; Female; Indoles; Isoquinolines; Liver; Mammary Neoplasms, Animal; Neoplasms, Experimental; Rats; Rats, Wistar; Tetrahydroisoquinolines; Trabectedin

2004